# CHEPLAPHARM ARZNEIMITTEL Cheplapharm Arzneimittel GmbH

CHEPLAPHARM ARZNEIMITTEL Cheplapharm Arzneimittel GmbH is a security (CUSIP 16412EAA5) tracked across SEC portfolio filings. 5 registered fund positions totaling $4.5M via N-PORT as of 2024-08-31.

## Summary

- Issuer: CHEPLAPHARM ARZNEIMITTEL
- Class: Cheplapharm Arzneimittel GmbH
- CUSIP: 16412EAA5
- Asset category: DBT
- 13F holders: 0
- N-PORT fund positions: 5
- N-PORT value: $4.5M
- N-PORT report: 2024-08-31

## Top fund holders (N-PORT)

| Fund | Registrant | Value | % of fund |
| --- | --- | --- | --- |
| Guggenheim Credit Allocation Fund | Guggenheim Credit Allocation Fund | $2.3M | 107.88% |
| Delaware Ivy High Income Opportunities Fund | Ivy High Income Opportunities Fund | $1.4M | 71.80% |
| BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. | BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. | $418K | 30.23% |
| [Delaware Enhanced Global Dividend & Income Fund](https://search.stillhousedata.com/fund/S000000000) | Delaware Enhanced Global Dividend & Income Fund | $186K | 28.15% |
| [Delaware Investments Dividend & Income Fund, Inc](https://search.stillhousedata.com/fund/S000000000) | Delaware Investments Dividend & Income Fund, Inc | $177K | 26.77% |

## More

- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/security/16412EAA5.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.